Friday, February 07, 2020 11:33:53 AM
On a different point of interest I contacted Merck a month ago and asked a question about Keynote 890 where Keytruda and Tavo is used with TNBC and is the subject of the good interim results in May and December. I asked them if they were aware that CGP was getting involved with OSM. I didn't really expect an answer but they did answer. They said they were well aware of what was going on but they couldn't comment any further. I thought that might be of interest to some of you. I told Dan about contacting Merck. All he said was yes and didn't comment further and I didn't proceed any further.
The CGP deal has passed. That's great!
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM